Anthony H Nguyen
Examiner (ID: 17425)
Most Active Art Unit | 2854 |
Art Unit(s) | 3307, 2854, 2853 |
Total Applications | 2014 |
Issued Applications | 1600 |
Pending Applications | 48 |
Abandoned Applications | 337 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 9737509
[patent_doc_number] => 20140273226
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'CRISPR/CAS SYSTEMS FOR GENOMIC MODIFICATION AND GENE MODULATION'
[patent_app_type] => utility
[patent_app_number] => 14/216655
[patent_app_country] => US
[patent_app_date] => 2014-03-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 41
[patent_figures_cnt] => 41
[patent_no_of_words] => 33975
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14216655
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/216655 | CRISPR/Cas systems for genomic modification and gene modulation | Mar 16, 2014 | Issued |
Array
(
[id] => 9735839
[patent_doc_number] => 20140271551
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'Synthetic Adeno-Associated Virus Inverted Terminal Repeats'
[patent_app_type] => utility
[patent_app_number] => 14/211927
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 20941
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14211927
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/211927 | Synthetic adeno-associated virus inverted terminal repeats | Mar 13, 2014 | Issued |
Array
(
[id] => 12411981
[patent_doc_number] => 09970932
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-05-15
[patent_title] => Non-covalent patterned chemical features and use thereof in MALDI-based quality control
[patent_app_type] => utility
[patent_app_number] => 14/773751
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15403
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 176
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773751
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773751 | Non-covalent patterned chemical features and use thereof in MALDI-based quality control | Mar 13, 2014 | Issued |
Array
(
[id] => 10676435
[patent_doc_number] => 20160022580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-28
[patent_title] => 'LIPID NANOPARTICLES FOR TRANSFECTION AND RELATED METHODS'
[patent_app_type] => utility
[patent_app_number] => 14/775539
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 17016
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775539
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775539 | Lipid nanoparticles for transfection and related methods | Mar 13, 2014 | Issued |
Array
(
[id] => 13234931
[patent_doc_number] => 10130649
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-11-20
[patent_title] => Synergistic enhancement of the delivery of nucleic acids via blended formulations
[patent_app_type] => utility
[patent_app_number] => 14/775818
[patent_app_country] => US
[patent_app_date] => 2014-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 26749
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 135
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14775818
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/775818 | Synergistic enhancement of the delivery of nucleic acids via blended formulations | Mar 13, 2014 | Issued |
Array
(
[id] => 14485521
[patent_doc_number] => 10329529
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-06-25
[patent_title] => Enhanced placental stem cells and uses thereof
[patent_app_type] => utility
[patent_app_number] => 14/774250
[patent_app_country] => US
[patent_app_date] => 2014-03-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 43918
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 48
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14774250
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/774250 | Enhanced placental stem cells and uses thereof | Mar 12, 2014 | Issued |
Array
(
[id] => 9737206
[patent_doc_number] => 20140272924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-09-18
[patent_title] => 'TRANSPLANTATION AND GROWTH OF HUMAN FETAL ORGANS IN NON-HUMAN ANIMAL HOSTS'
[patent_app_type] => utility
[patent_app_number] => 14/205871
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 7123
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14205871
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/205871 | TRANSPLANTATION AND GROWTH OF HUMAN FETAL ORGANS IN NON-HUMAN ANIMAL HOSTS | Mar 11, 2014 | Abandoned |
Array
(
[id] => 9771315
[patent_doc_number] => 20140294978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-10-02
[patent_title] => 'CATIONIC LIPID'
[patent_app_type] => utility
[patent_app_number] => 14/206193
[patent_app_country] => US
[patent_app_date] => 2014-03-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 20216
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14206193
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/206193 | CATIONIC LIPID | Mar 11, 2014 | Abandoned |
Array
(
[id] => 10692452
[patent_doc_number] => 20160038598
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-02-11
[patent_title] => 'Modified Poly(Beta-Amino Ester)s for Drug Delivery'
[patent_app_type] => utility
[patent_app_number] => 14/773671
[patent_app_country] => US
[patent_app_date] => 2014-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 13698
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14773671
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/773671 | Modified Poly(Beta-Amino Ester)s for Drug Delivery | Mar 9, 2014 | Abandoned |
Array
(
[id] => 10940001
[patent_doc_number] => 20140343020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'METHODS OF USING SUBSTITUTED TETRACYCLINE COMPOUNDS TO MODULATE RNA'
[patent_app_type] => utility
[patent_app_number] => 14/201401
[patent_app_country] => US
[patent_app_date] => 2014-03-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 19709
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14201401
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/201401 | METHODS OF USING SUBSTITUTED TETRACYCLINE COMPOUNDS TO MODULATE RNA | Mar 6, 2014 | Abandoned |
Array
(
[id] => 10760690
[patent_doc_number] => 20160106842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-21
[patent_title] => 'LIPIDS AND LIPID COMPOSITIONS FOR THE DELIVERY OF ACTIVE AGENTS'
[patent_app_type] => utility
[patent_app_number] => 14/779939
[patent_app_country] => US
[patent_app_date] => 2014-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 67975
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14779939
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/779939 | Lipids and lipid compositions for the delivery of active agents | Mar 5, 2014 | Issued |
Array
(
[id] => 10579814
[patent_doc_number] => 09301923
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-04-05
[patent_title] => 'Lipids, lipid compositions, and methods of using them'
[patent_app_type] => utility
[patent_app_number] => 14/197124
[patent_app_country] => US
[patent_app_date] => 2014-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 63570
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14197124
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/197124 | Lipids, lipid compositions, and methods of using them | Mar 3, 2014 | Issued |
Array
(
[id] => 10925909
[patent_doc_number] => 20140328931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-06
[patent_title] => 'NUCLEIC ACID PARTICLES, METHODS AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/190983
[patent_app_country] => US
[patent_app_date] => 2014-02-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 13980
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14190983
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/190983 | NUCLEIC ACID PARTICLES, METHODS AND USE THEREOF | Feb 25, 2014 | Abandoned |
Array
(
[id] => 9957768
[patent_doc_number] => 09005972
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-04-14
[patent_title] => 'Inkjet printing of tissues and cells'
[patent_app_type] => utility
[patent_app_number] => 14/185090
[patent_app_country] => US
[patent_app_date] => 2014-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 15
[patent_no_of_words] => 13306
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 139
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14185090
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/185090 | Inkjet printing of tissues and cells | Feb 19, 2014 | Issued |
Array
(
[id] => 10649590
[patent_doc_number] => 09365829
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-06-14
[patent_title] => 'Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof'
[patent_app_type] => utility
[patent_app_number] => 14/185716
[patent_app_country] => US
[patent_app_date] => 2014-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 33
[patent_figures_cnt] => 35
[patent_no_of_words] => 22267
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14185716
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/185716 | Cells genetically modified to comprise pancreatic islet glucokinase and uses thereof | Feb 19, 2014 | Issued |
Array
(
[id] => 10414732
[patent_doc_number] => 20150299742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-10-22
[patent_title] => 'COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS'
[patent_app_type] => utility
[patent_app_number] => 14/182822
[patent_app_country] => US
[patent_app_date] => 2014-02-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15571
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14182822
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/182822 | COMPOSITIONS AND METHODS FOR ENHANCING TOLERANCE FOR THE PRODUCTION OF ORGANIC CHEMICALS PRODUCED BY MICROORGANISMS | Feb 17, 2014 | Abandoned |
Array
(
[id] => 10938952
[patent_doc_number] => 20140341972
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-11-20
[patent_title] => 'METHOD TO INDUCE NEOVASCULAR FORMATION AND TISSUE REGENERATION'
[patent_app_type] => utility
[patent_app_number] => 14/176616
[patent_app_country] => US
[patent_app_date] => 2014-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 14145
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14176616
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/176616 | METHOD TO INDUCE NEOVASCULAR FORMATION AND TISSUE REGENERATION | Feb 9, 2014 | Abandoned |
Array
(
[id] => 10529125
[patent_doc_number] => 09255254
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-02-09
[patent_title] => 'Nylanderia fulva virus'
[patent_app_type] => utility
[patent_app_number] => 14/175371
[patent_app_country] => US
[patent_app_date] => 2014-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10651
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14175371
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/175371 | Nylanderia fulva virus | Feb 6, 2014 | Issued |
Array
(
[id] => 10656455
[patent_doc_number] => 20160002600
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-07
[patent_title] => 'COMPOSITION FOR PROMOTING CARDIAC DIFFERENTIATION OF PLURIPOTENT STEM CELL COMPRISING EGFR INHIBITOR'
[patent_app_type] => utility
[patent_app_number] => 14/772991
[patent_app_country] => US
[patent_app_date] => 2014-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9711
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14772991
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/772991 | Composition for promoting cardiac differentiation of pluripotent stem cell comprising EGFR inhibitor | Feb 4, 2014 | Issued |
Array
(
[id] => 11851708
[patent_doc_number] => 20170226201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-08-10
[patent_title] => 'Methods of diagnosing and treating hyperproliferative disorders'
[patent_app_type] => utility
[patent_app_number] => 14/146387
[patent_app_country] => US
[patent_app_date] => 2014-01-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 22981
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 27
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14146387
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/146387 | Methods of diagnosing and treating hyperproliferative disorders | Jan 1, 2014 | Abandoned |